Gland Pharma Q2 Results: Profit rises 12% to Rs 184 crore
Gland Pharma on Monday reported 12 per cent year-on-year increase in profit after tax (PAT) at Rs 184 crore for the September quarter, aided by strong performance by CDMO arm Cenexi.
Gland Pharma on Monday reported 12 per cent year-on-year increase in profit after tax (PAT) at Rs 184 crore for the September quarter, aided by strong performance by CDMO arm Cenexi.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
